Cite
HARVARD Citation
Schmidt, L. et al. (2016). Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC. Lung cancer. pp. 8-14. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schmidt, L. et al. (2016). Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC. Lung cancer. pp. 8-14. [Online].